Gastric Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age between 18 and 80 years; 2.Pathologically confirmed gastric adenocarcinoma via biopsy; 3.Staged as Stage IA according to the 8th Edition TNM Classification of the AJCC (American Joint Committee on Cancer); 4.Tumor size 2 cm away from both the esophagogastric junction (EGJ) and the pylorus; 5.ECOG performance status of 0 or 1.
Exclusion criteria
Exclusion criteria: 1.Patients who meet the indications for endoscopic resection, specifically: (1) Differentiated adenocarcinoma, ulcer-negative (UL0), macroscopic mucosal cancer (cT1a), regardless of lesion diameter; (2) Differentiated adenocarcinoma, ulcer-positive (UL1), macroscopic mucosal cancer (cT1a), with a lesion diameter <= 3 cm; (3) Undifferentiated adenocarcinoma, ulcer-negative (UL0), macroscopic mucosal cancer (cT1a), with a lesion diameter <= 2 cm. 2.Patients with concurrent malignancies (other co-existing tumors); 3.Patients who have received preoperative chemoradiotherapy or undergone other upper abdominal surgeries (excluding laparoscopic cholecystectomy); 4.Patients with multiple gastric lesions, cancers in other organs, or other conditions that do not meet the study requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical Complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| R0 Resection Rate;3-year Disease-Free Survival (DFS) Rate; | — |
Countries
China
Contacts
Peking University Cancer Hospital